International consortium for low-grade serous ovarian cancer research

The International Consortium for Low-Grade Serous Ovarian Cancer Research (ICLC) is an international research group co-founded by our founder, Jane Ludemann, in 2020.

Jane established the ICLC to build on the work of the Low-Grade Serous Ovarian Cancer Initiative, uniting leading LGSOC researchers from around the world to accelerate progress. With the support of renowned expert Dr David Gershenson, New Zealand-based researcher Associate Professor Heather Cunliffe, and seed funding from the Ludemann family, Jane’s vision has become a reality.

The ICLC comprises over 20 LGSOC researchers from around the world, including those supported by the LGSOC Initiative, such as Dr Mark Carey (Canada), Professor Charlie Gourley and Dr Robb Hollis (UK), Dr Rachel Grisham, Dr KK Wong, and Dr David Gershenson (US).